What is the current Price Target for the Kobayashi Pharmaceutical stock?

The average Kobayashi Pharmaceutical target price is ¥5,635.50. This is -4.24% lower than the current stock price. The highest price target is 23.11%, the lowest is -32.21%. 9 Analysts have issued a price target Kobayashi Pharmaceutical 2027 .

How high will the Kobayashi Pharmaceutical stock rise?

No reliable answer can be given as to how high the Kobayashi Pharmaceutical stock will rise. The performance of stocks, including the Kobayashi Pharmaceutical stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kobayashi Pharmaceutical stock today?

The performance of Kobayashi Pharmaceutical stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kobayashi Pharmaceutical stock fall?

The decline in Kobayashi Pharmaceutical stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kobayashi Pharmaceutical Forecast, price target & analysts

¥5,885.00

0.43%

Tokyo, Sep 24, 03:30 pm JST.

ISIN

JP3301100008

Symbol

4967

Sector

Household & Personal Products

Industry

Personal Care Products

Overview Dividends Analysts Charts Strategies

Kobayashi Pharmaceutical Target price 2026 - Analyst rating & recommendation

Kobayashi Pharmaceutical Classifications & Recommendation

Buy

14%

Hold

43%

Sell

43%

Kobayashi Pharmaceutical Price Target

Target Price	¥5,635.50
Price	¥5,885.00
Deviation	4.24% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Kobayashi Pharmaceutical 2027 . The average Kobayashi Pharmaceutical target price is ¥5,635.50. This is 4.24% register free of charge lower than the current stock price. The highest price target is ¥7,245.00 23.11% register free of charge , the lowest is ¥3,989.50 32.21% register free of charge .
	A rating was issued by 14 analysts: 2 Analysts recommend Kobayashi Pharmaceutical to buy, 6 to hold and 6 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kobayashi Pharmaceutical stock has an average upside potential 2027 of 4.24% register free of charge . Most analysts recommend the Kobayashi Pharmaceutical stock at Sell or hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Revenue Billion ¥	165.74	173.93
	0.09%	4.94%
EBITDA Margin	12.19%	12.67%
	32.05%	3.96%

9 Analysts have issued a sales forecast Kobayashi Pharmaceutical 2026 . The average Kobayashi Pharmaceutical sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	¥166b	0.09%
2026	¥174b 4.94% unlock
2027	¥181b 4.33% unlock
2028	¥189b 3.88% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share ¥	49.18	139.45
	63.68%	183.55%
P/E		42.20
EV/Sales		2.13

9 Analysts have issued a Kobayashi Pharmaceutical forecast for earnings per share. The average Kobayashi Pharmaceutical EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	¥49.18	63.68%
2026	¥139.45 183.55% unlock
2027	¥183.43 31.54% unlock
2028	¥226.76 23.62% unlock

Current	269.21	689.05%
2026	42.20 84.32% unlock
2027	32.08 23.98% unlock
2028	25.95 19.11% unlock

Based on analysts' sales estimates for 2026, the Kobayashi Pharmaceutical stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	2.21	3.27%
2026	2.13 3.67% unlock
2027	2.04 4.15% unlock
2028	1.96 3.74% unlock

Current	2.60	0.93%
2026	2.50 3.71% unlock
2027	2.39 4.15% unlock
2028	2.31 3.74% unlock

Kobayashi Pharmaceutical...

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now